Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa Study of MIV-711 in Knee Osteoarthritis
2015-003230-26Phase 2Completed
- Sponsor
- Medivir
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in knee osteoarthritis (OA) comparing MIV-711 with Placebo (2 arms). Primary endpoint: Change in average target knee pain. Started Oct 2015; status: completed.
02
Drugs
MIV-711
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2015-003230-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003230-26.